Exicure (XCUR) Gains from Investment Securities (2017 - 2026)
Exicure (XCUR) reported Gains from Investment Securities of -$37000.0 for Q1 2026, down 42.31% on a YoY basis from -$64133.3 in Q1 2025, and down 102.38% quarter-over-quarter from $1.6 million in Q4 2025.
Exicure (XCUR) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Exicure has reported Gains from Investment Securities for 9 years, with the latest figure at -$37000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 42.31% year-over-year to -$37000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 6526.92% YoY), and the FY2025 full-year result was $1.6 million, changed N/A from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$37000.0, down from $1.6 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $1.6 million in Q4 2025, with the low at -$632000.0 in Q3 2023.
- Historically, Gains from Investment Securities has averaged $123923.1 across 4 years, with a median of -$24000.0 in 2022.
- The largest YoY upside for Gains from Investment Securities was 1596.15% in 2023 against a maximum downside of 18100.0% in 2023.
- Exicure's Gains from Investment Securities stood at $52000.0 in 2022, then surged by 1596.15% to $882000.0 in 2023, then surged by 76.08% to $1.6 million in 2025, then tumbled by 102.38% to -$37000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$37000.0 (Q1 2026), $1.6 million (Q4 2025), and -$4000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Exicure | 17.53 Mn | 14.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37,000.00 |
| Mar 31, 2026 | -37,000.00 |
| Dec 31, 2025 | 1.55 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | 159,000.00 |
| Jun 30, 2025 | 159,000.00 |
| Mar 31, 2025 | -26,000.00 |
| Mar 31, 2025 | -26,000.00 |
| Dec 31, 2023 | 882,000.00 |
| Dec 31, 2023 | 882,000.00 |
| Sep 30, 2023 | -632,000.00 |
| Sep 30, 2023 | -632,000.00 |
| Jun 30, 2023 | -108,000.00 |
| Jun 30, 2023 | -108,000.00 |
| Mar 31, 2023 | -180,000.00 |
| Mar 31, 2023 | -180,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Dec 31, 2022 | 52,000.00 |